• Bilirubin Total, Amniotic Fluid
  • Compatibility Tests (Crossmatch), ABO, Rh Typing
  • Angelman syndrome
  • Treponema pallidum Antibody, IgG by IFA (FTA-ABS), Serum
  • X-Inactivation (XIST), Xq13.2 Deletion
  • Ova and Parasites, Stool
  • UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
  • Chikungunya Virus Antibody, IgG
  • Vitamin D, 25-Hydroxy, Total
  • HIV-1 Genotyping and Tropism by Next Generation Sequencing (DEEPGEN)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
Medical Test

Overview
Access to Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS) is restricted.